Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free VALN Stock Alerts

Valneva (VALN) Short Interest Ratio & Short Volume

Valneva logo
$5.94 +0.07 (+1.19%)
As of 02:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Valneva Short Interest Overview

As of April 30, 2026, Valneva (VALN) had a short interest of 152,470 shares sold short, representing 0.21% of the public float. This marks a 4.72% increase in short interest since the prior report. The short interest ratio (days to cover) is 1.2, meaning it would take 1.2 days of the average trading volume of 65,311 shares to cover all short positions.

Current Short Interest
152,470 shares
Previous Short Interest
145,600 shares
Change Vs. Previous Month
4.72%
Dollar Volume Sold Short
$820.29 thousand
Short Interest Ratio
1.2 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
86,110,000 shares
Short Percent of Float
0.21%
Today's Trading Volume
38,558 shares
Average Trading Volume
65,311 shares
Today's Volume Vs. Average
59%
Short Selling Valneva?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Valneva and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

VALN Short Interest Over Time

VALN Days to Cover Over Time

VALN Percentage of Float Shorted Over Time

Valneva Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2026152,470 shares $820.29 thousand +4.7%0.2%1.21 $5.38
4/15/2026145,600 shares $877.97 thousand -5.1%0.2%1.71 $6.03
3/31/2026153,342 shares $958.39 thousand -11.7%0.2%0.77 $6.25
3/13/2026173,642 shares $1.84 million +25.4%0.2%12.71 $10.61
2/27/2026138,488 shares $1.54 million -0.6%0.2%6.68 $11.09
2/13/2026139,314 shares $1.40 million -2.3%0.2%9.73 $10.08
1/30/2026142,590 shares $1.30 million -3.7%0.2%18.27 $9.12
1/15/2026148,067 shares $1.47 million +3.9%0.2%8.13 $9.95
12/31/2025142,480 shares $1.26 million -8.0%0.2%5.44 $8.82
12/15/2025154,873 shares $1.33 million -4.5%0.2%8.56 $8.60
11/28/2025162,133 shares $1.52 million -14.8%0.2%7.54 $9.35
11/14/2025190,353 shares $1.72 million +21.3%0.3%8.27 $9.05
10/31/2025156,883 shares $1.45 million -2.6%0.2%6.12 $9.27
10/15/2025161,000 shares $1.69 million +1,198.4%0.2%1.8 $10.50
9/30/202512,400 shares $151.28 thousand -33.7%0.0%0.1 $12.20
9/15/202518,700 shares $166.99 thousand +33.6%0.0%0.2 $8.93
8/31/202514,000 shares $123.90 thousand -81.3%0.0%0.2 $8.85
8/15/202574,900 shares $863.60 thousand +64.6%0.1%1.2 $11.53
7/31/202545,500 shares $334.43 thousand +91.2%0.1%0.9 $7.35
7/15/202523,800 shares $153.51 thousand -100.0%0.0%0.6 $6.45
6/30/202583,130,000 shares $471.35 million +3,463,650.0%2.0%2.2 $5.67
6/15/20252,400 shares $14.42 thousand +14.3%0.0%0 $6.01
5/31/20252,100 shares $13.19 thousand -56.3%0.0%0 $6.28
5/15/20254,800 shares $29.62 thousand -27.3%0.0%0.1 $6.17
4/30/20256,600 shares $41.84 thousand -33.3%0.0%0.1 $6.34
4/15/20259,900 shares $69.80 thousand -49.2%0.0%0.1 $7.05
3/31/202519,500 shares $130.85 thousand +15.4%0.0%0.2 $6.71
3/15/202516,900 shares $114.92 thousand +191.4%0.0%0.3 $6.80
2/28/20255,800 shares $39.15 thousand -84.2%0.0%0.1 $6.75
2/15/202536,700 shares $244.79 thousand -7.8%0.1%0.6 $6.67
1/31/202539,800 shares $230.04 thousand +73.8%0.1%0.8 $5.78
1/15/202522,900 shares $98.70 thousand +44.0%0.0%0.6 $4.31
12/31/202415,900 shares $69.48 thousand -34.6%0.0%0.4 $4.37
12/15/202424,300 shares $95.50 thousand -20.6%0.0%0.8 $3.93
11/30/202430,600 shares $123.93 thousand +111.0%0.0%1.3 $4.05
11/15/202414,500 shares $67.43 thousand -69.9%0.0%0.7 $4.65
10/31/202448,200 shares $272.33 thousand -12.7%0.1%2.7 $5.65
10/15/202455,200 shares $306.36 thousand +10.4%0.1%4 $5.55
9/30/202450,000 shares $302 thousand -4.0%0.1%4.4 $6.04
9/15/202452,100 shares $332.66 thousand +6.8%0.1%4.5 $6.39
Peptide Company Lands Exclusive MMA Wellness Partnership (Ad)

A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel

Read the full report on this small-cap peptide company now
8/31/202448,800 shares $357.22 thousand -10.6%0.1%5.2 $7.32
8/15/202454,600 shares $415.46 thousand -2.7%0.1%7.2 $7.61
7/31/202456,100 shares $412.34 thousand -6.0%0.1%6.9 $7.35
7/15/202459,700 shares $441.78 thousand -22.9%0.1%5.4 $7.40
6/30/202477,400 shares $542.57 thousand -3.3%0.1%6.8 $7.01
6/15/202480,000 shares $580 thousand +5.4%0.1%7.4 $7.25
5/31/202475,900 shares $683.10 thousand +5.7%0.1%7.4 $9.00
5/15/202471,800 shares $639.02 thousand +27.5%0.1%5.4 $8.90
4/30/202456,300 shares $419.44 thousand +14.0%0.1%4.2 $7.45
4/15/202449,400 shares $419.90 thousand +4.0%0.1%5 $8.50
3/31/202447,500 shares $376.20 thousand +12.0%0.1%4.8 $7.92
3/15/202442,400 shares $326.90 thousand +49.8%0.1%4.2 $7.71
2/29/202428,300 shares $199.80 thousand +434.0%0.0%3.1 $7.06
2/15/20245,300 shares $44.15 thousand -32.9%0.0%0.9 $8.33
1/31/20247,900 shares $64.39 thousand +102.6%0.0%1.3 $8.15
1/15/20243,900 shares $37.52 thousand -7.1%0.0%0.6 $9.62
12/31/20234,200 shares $43.55 thousand -26.3%0.0%0.6 $10.37
12/15/20235,700 shares $61.33 thousand +7.6%0.0%0.8 $10.76
11/30/20235,300 shares $65.46 thousand -54.7%0.0%0.8 $12.35
11/15/202311,700 shares $148.71 thousand +333.3%0.0%1.7 $12.71
10/31/20232,700 shares $30.94 thousand -64.0%N/A0.5 $11.46
10/15/20237,500 shares $85.13 thousand +13.6%0.0%1.3 $11.35
9/30/20236,600 shares $76.43 thousand No Change0.0%1.4 $11.58
9/15/20236,600 shares $91.81 thousand +24.5%0.0%1.3 $13.91
8/31/20235,300 shares $74.09 thousand -1.9%0.0%0.8 $13.98
8/15/20235,400 shares $71.39 thousand -25.0%0.0%0.5 $13.22
7/31/20237,200 shares $106.69 thousand -40.0%0.0%0.7 $14.82
7/15/202312,000 shares $186.54 thousand -2.4%0.0%1.1 $15.55
6/30/202312,300 shares $181.43 thousand -23.1%0.0%1.1 $14.75
6/15/202316,000 shares $227.43 thousand -10.6%0.0%1.5 $14.21
5/31/202317,900 shares $204.06 thousand -9.6%0.0%2.1 $11.40
5/15/202319,800 shares $264.53 thousand -2.0%0.0%4.7 $13.36
4/30/202320,200 shares $190.79 thousand -16.2%0.0%4 $9.45
4/15/202324,100 shares $273.39 thousand -5.9%0.0%4.4 $11.34
3/31/202325,600 shares $262.40 thousand -1.2%0.0%4.6 $10.25
3/15/202325,900 shares $290.08 thousand -8.5%0.0%4.5 $11.20
2/28/202328,300 shares $331.40 thousand +9.3%0.0%5.1 $11.71
2/15/202325,900 shares $334.24 thousand -12.8%0.0%4.7 $12.91
1/31/202329,700 shares $398.05 thousand -7.8%0.0%6.5 $13.40
1/15/202332,200 shares $464.49 thousand +0.9%0.1%7.7 $14.43
12/30/202231,900 shares $405.77 thousand +48.4%0.1%7.8 $12.72
12/15/202221,500 shares $275.20 thousand -37.3%0.0%4.4 $12.80
11/30/202234,300 shares $438.70 thousand +0.6%0.1%6.2 $12.79
11/15/202234,100 shares $495.81 thousand +2.7%0.1%5.9 $14.54
10/31/202233,200 shares $441.48 thousand -9.3%0.1%4.2 $13.30
10/15/202236,600 shares $447.98 thousand +7.0%0.1%4 $12.24
9/30/202234,200 shares $345.42 thousand -10.7%0.1%3.2 $10.10
9/15/202238,300 shares $653.78 thousand -5.9%0.1%2.7 $17.07
8/31/202240,700 shares $756.61 thousand -6.4%0.1%1.6 $18.59
8/15/202243,500 shares $925.25 thousand +11.5%0.1%1.7 $21.27
Peptide Company Lands Exclusive MMA Wellness Partnership (Ad)

A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel

Read the full report on this small-cap peptide company now
7/31/202239,000 shares $789.47 thousand -18.8%0.1%1.5 $20.24
7/15/202248,000 shares $972 thousand -23.7%0.1%1.8 $20.25
6/30/202262,900 shares $1.43 million +64.2%0.1%2.2 $22.70
6/15/202238,300 shares $598.25 thousand +0.5%0.1%1.4 $15.62
5/31/202238,100 shares $933.83 thousand +4.4%N/A2.7 $24.51
5/15/202236,500 shares $909.22 thousand +0.8%N/A2.3 $24.91
4/30/202236,200 shares $942.29 thousand -7.2%N/A2.3 $26.03
4/15/202239,000 shares $1.47 million -12.4%N/A1.6 $37.57
3/31/202244,500 shares $1.53 million -28.5%N/A1 $34.30
3/15/202262,200 shares $2.22 million -11.7%N/A1.2 $35.66
2/28/202270,400 shares $2.30 million -4.1%N/A1.1 $32.72
2/15/202273,400 shares $2.50 million -0.7%N/A1 $34.12
1/31/202273,900 shares $2.52 million +54.6%0.1%0.9 $34.07
1/15/202247,800 shares $1.79 million +20.7%0.1%0.5 $37.44
12/31/202139,600 shares $2.20 million -7.7%N/A0.4 $55.51
12/15/202142,900 shares $2.19 million +78.8%0.1%0.4 $50.98
11/30/202124,000 shares $1.55 million -35.8%0.1%0.2 $64.55
11/15/202137,400 shares $1.79 million -2.6%0.1%0.3 $47.77
10/29/202138,400 shares $1.71 million +598.2%0.1%0.3 $44.61
10/15/20215,500 shares $154.28 thousand +22.2%0.0%0.1 $28.05
9/30/20214,500 shares $141.30 thousand -59.5%0.0%0.1 $31.40
9/15/202111,100 shares $321.35 thousand -40.6%0.0%0.2 $28.95
8/31/202118,700 shares $991.10 thousand +6.9%0.0%0.7 $53.00
8/13/202117,500 shares $466.38 thousand No Change0.0%2.2 $26.65

VALN Short Interest - Frequently Asked Questions

Short interest is the volume of Valneva shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 152,470 shares of VALN short. 0.21% of Valneva's shares are currently sold short. Learn More on Valneva's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VALN shares currently have a short interest ratio of 1.2. Learn More on Valneva's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.21% of Valneva's floating shares are currently sold short.

Valneva saw a increase in short interest in April. As of April 30th, there was short interest totaling 152,470 shares, an increase of 4.7% from the previous total of 145,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.21% of Valneva's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Valneva: Amylyx Pharmaceuticals, Inc. (15.18%), Recursion Pharmaceuticals, Inc. (35.31%), Iovance Biotherapeutics, Inc. (27.86%), Syndax Pharmaceuticals, Inc. (23.43%), Ardelyx, Inc. (10.08%), Nurix Therapeutics, Inc. (19.90%), Rapport Therapeutics, Inc. (7.37%), Nanobiotix S.A. - Sponsored ADR (0.08%), Nuvation Bio Inc. (20.80%), Monte Rosa Therapeutics, Inc. (19.15%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling VALN is an investing strategy that aims to generate trading profit from Valneva as its price is falling. VALN shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Valneva occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VALN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VALN, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like VALN:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:VALN) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...
Equiscreen | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Elon’s ‘iPhone’ Could 10x Apple’s iPhone
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel